Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Alexion Pharm Inc (ALXN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 30,411,894
  • Shares Outstanding, K 223,469
  • Annual Sales, $ 4,131 M
  • Annual Income, $ 77,600 K
  • 60-Month Beta 1.55
  • Price/Sales 7.30
  • Price/Cash Flow 14.92
  • Price/Book 3.28

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 2.01
  • Number of Estimates 6
  • High Estimate 2.11
  • Low Estimate 1.81
  • Prior Year 1.53
  • Growth Rate Est. (year over year) +31.37%

Price Performance

See More
Period Period Low Period High Performance
1-Month
125.70 +8.11%
on 03/08/19
138.32 -1.76%
on 03/04/19
+6.47 (+5.00%)
since 02/15/19
3-Month
92.56 +46.81%
on 12/24/18
138.32 -1.76%
on 03/04/19
+29.90 (+28.21%)
since 12/18/18
52-Week
92.56 +46.81%
on 12/24/18
140.77 -3.47%
on 09/28/18
+9.14 (+7.21%)
since 03/16/18

Most Recent Stories

More News
Alexion Announces Publication of Interim Data from Phase 3 Open-Label Extension Study Supporting Long-Term Efficacy and Safety of SOLIRIS(R) (Eculizumab) in Adult Patients with Generalized Myasthenia Gravis in Muscle & Nerve

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the publication of data from an interim analysis of the Phase 3 open-label extension study (ECU-MG-302) of REGAIN (ECU-MG-301)...

ALXN : 135.66 (-0.32%)
Alexion Pharm Set to Possibly Rebound After Yesterday's Selloff of 1.75%

Alexion Pharm (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $132.41 to a high of $134.10. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $132.66...

ALXN : 135.66 (-0.32%)
Why Is Alexion (ALXN) Up 9.7% Since Last Earnings Report?

Alexion (ALXN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ALXN : 135.66 (-0.32%)
Analysis: Positioning to Benefit within Bristol-Myers Squibb, AAR, Central Garden & Pet, Alexion Pharmaceuticals, Tribune Media, and Civitas Solutions -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Bristol-Myers Squibb Company (NYSE:BMY),...

CIVI : 17.76 (+0.11%)
CENTA : 26.42 (+0.49%)
AIR : 34.16 (-0.09%)
TRCO : 46.12 (unch)
BMY : 49.90 (-0.12%)
ALXN : 135.66 (-0.32%)
Alexion to Present at the Cowen 39th Annual Health Care Conference

Alexion Pharmaceuticals (Nasdaq: ALXN) today announced that management will present at the Cowen 39th Annual Health Care Conference in Boston, MA on Tuesday, March 12, 2019 at 11:20 a.m.,...

ALXN : 135.66 (-0.32%)
Alexion Pharm Shares Up 30.3% Since SmarTrend's Buy Recommendation (ALXN)

SmarTrend identified an Uptrend for Alexion Pharm (NASDAQ:ALXN) on January 4th, 2019 at $104.55. In approximately 2 months, Alexion Pharm has returned 30.25% as of today's recent price of $136.18.

ALXN : 135.66 (-0.32%)
Alexion Employees Raise Hands to Raise Awareness and #RallyforRare on Rare Disease Day

Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) is honored to support Rare Disease Day 2019 with the launch of #RallyforRare, a global social media campaign that aims to raise awareness of rare...

ALXN : 135.66 (-0.32%)
Alexion Pharm Has Returned 26.9% Since SmarTrend Recommendation (ALXN)

SmarTrend identified an Uptrend for Alexion Pharm (NASDAQ:ALXN) on January 4th, 2019 at $104.55. In approximately 2 months, Alexion Pharm has returned 26.93% as of today's recent price of $132.71.

ALXN : 135.66 (-0.32%)
Alexion to Present at the 8th Annual SVB Leerink Global Healthcare Conference

Alexion Pharmaceuticals (Nasdaq: ALXN) today announced that management will present at the 8th Annual SVB Leerink Global Healthcare Conference in New York, NY on Wednesday, February 27, 2019...

ALXN : 135.66 (-0.32%)
Despite M&A Spree, Biotech ETFs Slide on Mixed Earnings

Biotech stocks came up with mixed earnings and weighed on the related ETFs in the key reporting season.

IBB : 114.61 (+0.36%)
FBT : 152.18 (+0.48%)
BBH : 131.15 (-0.14%)
GILD : 65.62 (-0.02%)
AMGN : 192.11 (+0.45%)
BIIB : 329.49 (-0.12%)
ALXN : 135.66 (-0.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More Share

Trade ALXN with:

Business Summary

Alexion Pharmaceuticals, Inc. is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the innovation, development and commercialization of life-changing therapies. Alexion is the global leader in complement inhibition and has developed and commercializes...

See More

Key Turning Points

2nd Resistance Point 137.82
1st Resistance Point 136.95
Last Price 135.66
1st Support Level 134.92
2nd Support Level 133.76

See More

52-Week High 140.77
Last Price 135.66
Fibonacci 61.8% 122.35
Fibonacci 50% 116.67
Fibonacci 38.2% 110.98
52-Week Low 92.56

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar